Brief: Cortice Biosciences Reports 5.7% Stake In CNS Pharmaceuticals
Aug 2 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CORTICE BIOSCIENCES, INC. REPORTS 5.7% STAKE IN CNS
PHARMACEUTICALS INC AS OF JULY 29- SEC FILING
Source text for Eikon: ID:n0001193125-24-192870
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026